Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02515188Completed
Randomised, double-blind trial in Atrial fibrillation (AFib) comparing Propacetamol Group with Placebo Group (2 arms). Primary endpoint: Total Amount of Opioid Consumption at 1 day. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02515188.